Gel Electrophoresis As a Method for Classifying Inhibitors of Poly(ADP-ribose) Polymerases 1 and 2

Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2) play an important role in DNA damage repair in cells, and their inhibition is used for the treatment of certain oncological diseases. New PARP inhibitors are being actively developed and their mechanisms are being studied. This work shows that polyacrylamide gel electrophoresis of DNA complexes with PARP1 and PARP2 in the presence of inhibitors allows us to identify their effect on enzyme binding to DNA, as demonstrated by the inhibitors talazoparib, olaparib and veliparib. After addition of the substrate NAD+, this system can compare the efficiency of inhibition of the catalytic activity of PARP1 or PARP2 by the test compounds. It is crucial to consider both mechanisms for the search for new PARP1 and PARP2 inhibitors.

Authors

Institutions

Publication Details

Journal
Moscow University Biological Sciences Bulletin
Published
2024-12-01
DOI
https://doi.org/10.3103/s0096392525600176
Citations
2
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gel Electrophoresis As a Method for Classifying Inhibitors of Poly(ADP-ribose) Polymerases 1 and 2

A. A. Lobanova, Vasily M. Studitsky, Alexey V. Feofanov, Д. О. Кошкина et al.
2 citations
Moscow University Biological Sciences Bulletin
PARP inhibition in cancer therapy
0.57
article

Gel Electrophoresis As a Method for Classifying Inhibitors of Poly(ADP-ribose) Polymerases 1 and 2

A. A. Lobanova, Vasily M. Studitsky, Alexey V. Feofanov, Д. О. Кошкина, D. K. Nilov, Polina A. Chernikova, N. V. Maluchenko, А. Н. Коровина
article en
2 citations

Abstract

Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2) play an important role in DNA damage repair in cells, and their inhibition is used for the treatment of certain oncological diseases. New PARP inhibitors are being actively developed and their mechanisms are being studied. This work shows that polyacrylamide gel electrophoresis of DNA complexes with PARP1 and PARP2 in the presence of inhibitors allows us to identify their effect on enzyme binding to DNA, as demonstrated by the inhibitors talazoparib, olaparib and veliparib. After addition of the substrate NAD+, this system can compare the efficiency of inhibition of the catalytic activity of PARP1 or PARP2 by the test compounds. It is crucial to consider both mechanisms for the search for new PARP1 and PARP2 inhibitors.

Moscow University Biological Sciences BulletinVol. 79(4)
Fox Chase Cancer Center (US), Lomonosov Moscow State University (RU)
Clean water and sanitation
Openalex Percentile: Top 26%
PARP inhibition in cancer therapy
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.